Mentis Cura is a digital diagnostics company that uses machine learning to diagnose disorders of the central nervous system, such as dementia and ADHD. Mentis Cura's technology builds on a unique database of more than 3,000 EEG recordings from individuals with various brain disorders, many of whom have been followed clinically for over a decade.
Specialising in statistical pattern recognition systems, Mentis Cura has developed new neurodiagnostic aids that help identify objective physiological evidence of central nervous system disorders and monitor pharmaceutical interventions.
Established in Iceland in 2004 by PhD physicist Kristinn Johnsen, Mentis Cura is now headquartered in Oslo, Norway and has operating entities in Reykjavík, Iceland, and Tokyo, Japan. Mentis Cura currently has one CE marked product - Sigla® - on the market and distributors in numerous countries.
Mentis Cura founded in Iceland by Kristinn Johnsen.
Database with over 3,000 EEG records of patients (followed for 10+ years) continuously expanded.
Sigla launched in Iceland serving over 700 patients to date.
Collaboration with leading entities in the dementia and CNS field.
Proof-of-concept studies in UK, Sweden, Denmark, Norway and Iceland.
Mentis Cura headquarters established in Oslo, Norway.
Mentis Cura Asia hub established in Tokyo, Japan
Mentis Cura granted ISO 13485 Certification for medical devices.
Exclusive partnership agreement with Nihon Medi-Physics in Japan
Sigla launched in Italy
Kristinn Johnsen founded Mentis Cura in 2004 in Reykjavík, Iceland.
Kristinn has a sound scientific bacground and pharmaceutical experience. Before founding Mentis Cura Kristinn was a senior research scientist for Lyfjaþróun drug delivery company.
Kristinn holds a PhD in theoretical physics from the Technical University of Denmark, and did post-doctoral fellowships in Denmark and the United States.
Here you can find Mentis Cura's logo and other photographic material that is authorized for public use.
For media inquiries, please contact CEO Claire Button.